An inhalation version of CanSino Biologics' COVID-19 vaccine is being tested in a Phase II clinical trial, Chief Executive Yu Xuefeng said late on Wednesday.
Yu made the comment at a panel of the Global Health Forum of the Boao Forum for Asia.
An inhalation version of CanSino Biologics' COVID-19 vaccine is being tested in a Phase II clinical trial, Chief Executive Yu Xuefeng said late on Wednesday.
Yu made the comment at a panel of the Global Health Forum of the Boao Forum for Asia.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.